Appeals Court Rejects Novo Nordisk Challenge to Medicare Drug Pricing Plan
yubnub.news

Appeals Court Rejects Novo Nordisk Challenge to Medicare Drug Pricing Plan

Flags with the logo of Novo Nordisk, the maker of Ozempic and Wegovy, in a file image. Mads Claus Rasmussen/Ritzau Scanpix/AFP via Getty ImagesA federal appeals court on Oct. 6 rejected a challenge from…